1. Home
  2. LINK vs TCRX Comparison

LINK vs TCRX Comparison

Compare LINK & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interlink Electronics Inc.

LINK

Interlink Electronics Inc.

HOLD

Current Price

$3.29

Market Cap

59.5M

Sector

Technology

ML Signal

HOLD

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$1.05

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LINK
TCRX
Founded
1984
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
57.9M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
LINK
TCRX
Price
$3.29
$1.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$8.67
$8.50
AVG Volume (30 Days)
28.2K
443.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.18
EPS
N/A
N/A
Revenue
$11,679,000.00
$2,816,000.00
Revenue This Year
$8.30
$286.83
Revenue Next Year
$34.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$0.88
52 Week High
$15.15
$2.57

Technical Indicators

Market Signals
Indicator
LINK
TCRX
Relative Strength Index (RSI) 44.20 50.53
Support Level $2.76 $0.90
Resistance Level $4.11 $1.23
Average True Range (ATR) 0.30 0.07
MACD 0.02 0.01
Stochastic Oscillator 29.52 59.00

Price Performance

Historical Comparison
LINK
TCRX

About LINK Interlink Electronics Inc.

Interlink Electronics Inc is a sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. It designs, develops, manufactures and sells a range of force-sensing and gas-sensing technologies that incorporate its proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Its force-sensing products and solutions include sensor components, subassemblies, modules products that support effective, efficient cursor control and novel three-dimensional user inputs. Its Human Machine Interface technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical.

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Share on Social Networks: